Patents Assigned to ResQ Pharma, Inc.
  • Lipid emulsions and uses thereof
    Patent number: 12629334
    Abstract: The present disclosure provides lipid emulsions comprising at least 20 percent (w/v) lipid with an average particle size of about 200 to about 300 nm, and use thereof to treat subjects in need of lipid emulsion therapy.
    Type: Grant
    Filed: January 5, 2023
    Date of Patent: May 19, 2026
    Assignees: ResQ Pharma, Inc., The United States Government as Represented by The Department of Veterans Affairs
    Inventors: Guy Weinberg, Christopher Piers Bryant